KraneShares MSCI All China Health Care Index ETF (KURE)
| Assets | $126.14M |
| NAV | $22.13 |
| Expense Ratio | 0.65% |
| PE Ratio | 36.70 |
| Shares Out | 5.70M |
| Dividend (ttm) | $0.00 |
| Dividend Yield | 0.00% |
| Ex-Dividend Date | Dec 29, 2021 |
| 1-Year Return | -51.83% |
| Volume | 40,073 |
| Open | 22.72 |
| Previous Close | 22.05 |
| Day's Range | 22.03 - 22.35 |
| 52-Week Low | 18.79 |
| 52-Week High | 46.60 |
| Beta | 0.50 |
| Holdings | 89 |
| Inception Date | Feb 1, 2018 |
About KURE
The fund will invest at least 80% of its total assets in components of the underlying index, depositary receipts, representing such components and securities underlying depositary receipts in the underlying index. The underlying index is a free float adjusted market capitalization weighted index, subject to the 10/40 Constraint, which is designed to measure the equity market performance of Chinese companies in the healthcare sector. The fund is non-diversified.
Top 10 Holdings
42.53% of assets| Name | Symbol | Weight |
|---|---|---|
| WuXi Biologics (Cayman) Inc | 2269.HK | 9.45% |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A | 300760.SZ | 6.46% |
| Wuxi AppTec Co Ltd Class A | 603259.SS | 4.24% |
| Aier Eye Hospital Group Co Ltd Class A | 300015.SZ | 3.85% |
| Jiangsu Hengrui Pharmaceuticals Co Ltd Class A | 600276.SS | 3.65% |
| Zhangzhou Pientzehuang Pharmaceutical Co Ltd Class A | 600436.SS | 3.50% |
| CSPC Pharmaceutical Group Ltd | 1093.HK | 3.45% |
| BeiGene | BGNE | 2.86% |
| Chongqing Zhifei Biological Products Co Ltd Class A | 300122.SZ | 2.72% |
| Sino Biopharmaceutical Ltd | 1177.HK | 2.36% |
Dividends
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 29, 2021 | $0.000089 | Dec 31, 2021 |
| Dec 29, 2020 | $0.000109 | Dec 31, 2020 |
| Dec 27, 2019 | $0.057325 | Dec 31, 2019 |
| Dec 26, 2018 | $0.039344 | Dec 28, 2018 |
News
Valuation Opportunities Abound Within China's Healthcare Sector
The health care industry in China is expected to expand rapidly in the coming years with a rapidly aging population, growing infrastructure, and China's growing role in the global health care system thr...
KraneShares Debuts Umbrella China ETF
The newest ETF is a fund-of-funds composed of existing China ETFs.
A KURE-All for Bland Healthcare Exposure
In some form or fashion, hundreds of exchange traded funds offer exposure to Chinese equities. As the world's second-largest country has evolved, so have the related ETF offerings.
Healthcare Gains Drive Chinese Stocks Even Higher
Asian markets ended last week up, buoyed in part by a rally in healthcare firms, according to Reuters. The blue-chip CSI300 Index, which tracks the top 300 stocks traded on the Shenzhen Stock Exchange a...
Cover All the Hot Bases in Chinese Equity with This Model Portfolio
ETF investors looking for growth and innovation in China, can turn to the KraneShares Krane China Innovation Strategy. The strategy consists of a model portfolio that seeks to provide investors exposure...
5 Top-Performing ETFs of Last Week
Wall Street was downbeat last week on inflationary concerns and some downbeat economic data points.
Best-Performing ETF Areas of Last Week
Last week was slightly downbeat for Wall Street on talks of a capital gain tax hike with three big U.S. indexes remaining in the red.
Is Chinese Healthcare the Miracle KURE for Your Portfolio?
In the United States, healthcare is a dynamic sector home to defensive value stocks, disruptive growth names, and plenty of in-between. China offers a comparable level of healthcare dynamism, which inve...
Best Pharmaceutical ETFs for Q2 2021
The best pharmaceutical ETFs for Q2 2021 are KURE, MJJ, and POTX.
Best Healthcare ETFs for Q1 2021
The best healthcare ETFs for Q1 2021 are ARKG, PTH, and KURE.
Best Pharmaceutical ETFs for Q1 2021
The best pharmaceutical ETFs for Q1 2021 are KURE, XPH, and IHE.
The Tell: China's bouncing back, but don't bet on other emerging markets to join the ride
China's economy is bouncing back, but other emerging markets aren't likely to enjoy the spoils, says one economist.
Chinese stocks have biggest gains in 3 months
Yahoo Finance's Tom Belger reports on the latest stock news from China and Europe.
Best Healthcare ETFs for Q4 2020
The best healthcare ETFs for Q4 2020 are ARKG, KURE, and PTH.
Best Pharmaceutical ETFs for Q4 2020
The best pharmaceutical ETFs for Q4 2020 are KURE, XPH, and PJP.
5 Reasons to Bet on China ETFs
The Chinese economy returned to growth in the second quarter of 2020. This along with PBOC's targeted policy easing and China's solid tech industry make China investing winners in the recent trading ses...
3 Best Country ETFs of 1H That Survived the Pandemic
While most the countries' stocks have been beaten down badly in the pandemic, some still managed to trade in green for the first half of the year.
China Healthcare ETF (KURE) Hits New 52-Week High
The fund hit a 52-week high lately. Can this go further higher?
